|
Thermage FLX: Single-session standout
|
The new Thermage FLX adds speed and ease of use to the only monopolar radiofrequency (RF) device FDA-cleared for use on body and facial locations, including the eyelids, with a single treatment.
|
|
Topical rapamycin improves facial skin lesions in tuberous sclerosis complex
|
|
Topical rapamycin significantly improves facial angiofibromas secondary to tuberous sclerosis complex, according to data from a 6-month randomized placebo-controlled study. The 1% formulation of rapamycin performed better than 0.1% in a visual analysis but was not statistically significantly better, reported Mary Kay Koenig, MD, and colleagues in JAMA Dermatology. |
